Stephanie van Hoppe

162 Chapter 6 D. Iusuf, E. van de Steeg and A.H. Schinkel, Hepatocyte hopping of OATP1B substrates contributes to efficient hepatic detoxification, Clin Pharmacol Ther 92 (2012c), pp. 559-562. D. Iusuf, A. van Esch, M. Hobbs, M. Taylor, K.E. Kenworthy, E. van de Steeg, E. Wagenaar and A.H. Schinkel, Murine Oatp1a/1b uptake transporters control rosuvastatin systemic exposure without affecting its apparent liver exposure, Mol Pharmacol 83 (2013), pp. 919-929. L. Jain, S. Woo, E.R. Gardner, W.L. Dahut, E.C. Kohn, S. Kummar, D.R. Mould, G. Giaccone, R. Yarchoan, J. Venitz and W.D. Figg, Population pharmacokinetic analysis of sorafenib in patients with solid tumours, Br J Clin Pharmacol 72 (2011), pp. 294-305. R.V. Kondratov, P.G. Komarov, Y. Becker, A. Ewenson and A.V. Gudkov, Small molecules that dramatically alter multidrug resistance phenotype by modulating the substrate specificity of P-glycoprotein, Proc Natl Acad Sci U S A 98 (2001), pp. 14078-14083. J. Konig, F. Muller and M.F. Fromm, Transporters and drug-drug interactions: important determinants of drug disposition and effects, Pharmacol Rev 65 (2013), pp. 944-966. S.L. Koolen, J.H. Beijnen and J.H. Schellens, Intravenous-to-oral switch in anticancer chemotherapy: a focus on docetaxel and paclitaxel, Clin Pharmacol Ther 87 (2010), pp. 126-129. J.S. Lagas, C.W. Damen, R.A. vanWaterschoot, D. Iusuf, J.H. Beijnen andA.H. Schinkel, P-glycoprotein, multidrug- resistance associated protein 2, Cyp3a, and carboxylesterase affect the oral availability and metabolism of vinorelbine, Mol Pharmacol 82 (2012), pp. 636-644. C.S. Lancaster, J.A. Sprowl, A.L. Walker, S. Hu, A.A. Gibson and A. Sparreboom, Modulation of OATP1B-type transporter function alters cellular uptake and disposition of platinum chemotherapeutics, Mol Cancer Ther 12 (2013), pp. 1537-1544. H.H. Lee, B.F. Leake,W.Teft, R.G.Tirona, R.B. Kimand R.H. Ho, Contribution of hepatic organic anion-transporting polypeptides to docetaxel uptake and clearance, Mol Cancer Ther 14 (2015), pp. 994-1003. W. Lee, H. Glaeser, L.H. Smith, R.L. Roberts, G.W. Moeckel, G. Gervasini, B.F. Leake and R.B. Kim, Polymorphisms in human organic anion-transporting polypeptide 1A2 (OATP1A2): implications for altered drug disposition and central nervous system drug entry, J Biol Chem 280 (2005), pp. 9610-9617. S. Leuthold, B. Hagenbuch, N. Mohebbi, C.A. Wagner, P.J. Meier and B. Stieger, Mechanisms of pH-gradient driven transport mediated by organic anion polypeptide transporters, Am J Physiol Cell Physiol 296 (2009), pp. C570-582. H. Lu, S. Choudhuri, K. Ogura, I.L. Csanaky, X. Lei, X. Cheng, P.Z. Song and C.D. Klaassen, Characterization of organic anion transporting polypeptide 1b2-null mice: essential role in hepatic uptake/toxicity of phalloidin and microcystin-LR, Toxicol Sci 103 (2008), pp. 35-45. P. Martinez-Becerra, O. Briz, M.R. Romero, R.I. Macias, M.J. Perez, C. Sancho-Mateo, M.P. Lostao, J.M. Fernandez- Abalos and J.J. Marin, Further characterization of the electrogenicity and pH sensitivity of the human organic anion-transporting polypeptides OATP1B1 and OATP1B3, Mol Pharmacol 79 (2011), pp. 596-607. R.H. Mathijssen,W.J. Loos, J.Verweij and A. Sparreboom, Pharmacology of topoisomerase I inhibitors irinotecan (CPT-11) and topotecan, Curr Cancer Drug Targets 2 (2002), pp. 103-123. G. Minotti, P. Menna, E. Salvatorelli, G. Cairo and L. Gianni, Anthracyclines: molecular advances and pharmacologic developments in antitumor activity and cardiotoxicity, Pharmacol Rev 56 (2004), pp. 185- 229. N.R. Monks, S. Liu, Y. Xu, H. Yu, A.S. Bendelow and J.A. Moscow, Potent cytotoxicity of the phosphatase inhibitor microcystin LR and microcystin analogues in OATP1B1- and OATP1B3-expressing HeLa cells, Mol Cancer Ther 6 (2007), pp. 587-598. M. Muto, T. Onogawa, T. Suzuki, T. Ishida, T. Rikiyama, Y. Katayose, N. Ohuchi, H. Sasano, T. Abe and M. Unno, Human liver-specific organic anion transporter-2 is a potent prognostic factor for human breast carcinoma, Cancer Sci 98 (2007), pp. 1570-1576. T. Nakanishi and I. Tamai, Genetic polymorphisms of OATP transporters and their impact on intestinal absorption and hepatic disposition of drugs, Drug Metab Pharmacokinet 27 (2012), pp. 106-121. T. Nakanishi and I. Tamai, Putative roles of organic anion transporting polypeptides (OATPs) in cell survival and progression of human cancers, Biopharm Drug Dispos 35 (2014), pp. 463-484. M. Niemi, M.K. Pasanen and P.J. Neuvonen, Organic anion transporting polypeptide 1B1: a genetically polymorphic transporter of major importance for hepatic drug uptake, Pharmacol Rev 63 (2011), pp. 157-181.